Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura
Status:
Terminated
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Photodynamic therapy uses a drug, such as porfimer sodium, that is absorbed by
tumor cells. The drug becomes active when it is exposed to light. When the drug is active,
tumor cells are killed. Giving photodynamic therapy during surgery may kill any tumor cells
that remain after surgery.
PURPOSE: This phase II trial is studying the side effects and how well photodynamic therapy
given during surgery works in treating patients with resectable non-small cell lung cancer
that has spread to the pleura.
Phase:
Phase 2
Details
Lead Sponsor:
Abramson Cancer Center of the University of Pennsylvania